跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Platixon - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Platixon
Approved
STANDARD
Platixon
Venus Remedies Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
51fcf975a0b3aed4
Company
Venus Remedies Limited
Type
Standard
Approval Details
Approval Id
51fcf975a0b3aed4
Drug Approval Philippines Name
Platixon
Product Name
Platixon
Registration Number
DR-XY 48965
Brand Name
Platixon
Generic Name
Carboplatin
Dosage Form
Solution for Intravenous Infusion
Dosage Strength
450 mg/45 mL (10 mg/mL)
Manufacturer
Venus Remedies Limited
Importer
Endure Medical, Inc.
Distributor
Endure Medical, Inc.
Company Detail Path
/organization/venus-remedies-limited
Issuance Date
28 December 2023
Expiry Date
28 December 2028
Pharmacologic Category
Antineoplastic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
51fcf975a0b3aed4
Type
Standard
Back to Philippines FDA Approvals